Alvogen
| Company type | private |
|---|---|
| Founded | 2009 |
| Founder | Róbert Wessman |
| Headquarters | Pine Brook, New Jersey |
| Revenue | $1.1 billion (2017) |
| Owners | CVC Capital Partners and Temasek Holdings |
Number of employees | 2800 |
| Website | www |
Alvogen is a private, US-based pharmaceuticals company founded in 2009. Since 2015, it has been majority-owned by CVC Capital Partners and Temasek Holdings. Alvogen focuses on so-called 'difficult-to-make' generic drugs and injectables, and both produces its own products and markets the products of brand name pharmaceutical companies.